“There is only so much we can learn from photographs,” Professor Alexandra Meise tells The New York Times. “As much as a photograph is worth a thousand words, as the saying goes, a photograph cannot necessarily tell you intent or the legitimacy of a military objective.”
In an op-ed co-authored for the New York Daily News, Professor Woodrow Hartzog and Evan Sellinger argue that that face masks are important for protecting people from COVID-19, not facial surveillance.
In their latest co-authored op-ed, Professors Woodrow Hartzog and Evan Selinger argue that facial recognition is perfectly tailored to serve the worst impulses of humanity during a time of deep vulnerability: "The thing is, we already know enough to conclude that face recognition technology shouldn't be used to fight COVID-19."
How does the patent process work for vaccines in the US, and how does the ongoing global health crisis affect the law? On WGBH's Morning Edition, Professor Daniel Medwed gives a breakdown of the basic intellectual property law related to developing a vaccine for COVID-19.
Professor Wendy Parmet tells The Wichita Eagle the underlying consensus that appeared to be holding in the early stages of the pandemic is breaking down: "Public health orders are becoming yet another issue viewed through a political prism."
The School of Law hosted a virtual commencement celebration on Thursday, May 21. Watch the video highlights!
“The danger is, it’s a race to the bottom as more and more states reopen,” Professor Wendy Parmet tells The Boston Globe. "It will be harder and harder for governors to maintain stricter measures in their state. People are tired of the lockdowns and there is a pressure in opening up, but also a lot of risk.”
In a co-authored op-ed, Professor Brook Baker urges the president of South Africa to declare his support for the Solidarity Call to Action on the COVID-19 technology pool, which will be officially launched on 29 May 2020: “We remind President Ramaphosa that there is work to be done at home amending South Africa’s Patents Act, and instituting emergency measures to temporarily suspend patenting of COVID-19 medical products and to provide for automatic or mandatory compulsory licenses on such products should voluntary measures prove unsuccessful.”